1. Shalnova S, Kukushkin S, Manoshkina E, et al. Arterial hypertension and commitment of therapy. Doctor 2009; 12: 39–42. Russian (Shal'nova S., Kukushkin S., Manoshkina E. i dr. Arterial'naya gipertenziya i priverzhennost' terapii. Vrach 2009; 12: 39–42).
2. Karpov AYu. The combined hypotensive therapy – a way to achievement of target level of arterial pressure at patients with arterial hypertension. Atmosphere. Cardiology news 2013; 1: 22–6. Russian (Karpov A. Yu. Kombinirovannaya gipotenzivnaya terapiya – put' k dostizheniyu tselevogo urovnya arterial'nogo davleniya u patsientov s arterial'noi gipertenziei. Atmosfera. Novosti kardiologii 2013; 1: 22–6).
3. Moser M, Hebert P, Hennekens CR. An overview of the meta analysis of the hypertension treatment trials. Arch Intern Med 1991; 151: 1277–9.
4. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hy-pertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287: 1003–10.
5. Chobanian AN, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560–71.